November 30, 2016 5:30pm
… As speculation runs rampant
I say today what others won't, so you can do what others can't!
Pre-open indication’s tally: 0 hits and 2 miss
There are two things that investors need - interpretation of news and translation of market metrics concerning the stem, cell, gene and regenerative therapy sector to substantiate share pricing.
Members only. Please login.